Nuvectis Pharma Inc
(NVCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,442 | -19,000 | -22,260 | -19,085 | -12,890 |
| Other Working Capital | 4,401 | 1,895 | 1,601 | 3,819 | 1,494 |
| Other Operating Activity | 6,032 | 4,858 | 4,705 | 1,707 | 1,892 |
| Operating Cash Flow | $-16,009 | $-12,247 | $-15,954 | $-13,559 | $-9,504 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 31,210 | 12,036 | 16,481 | 31,879 | 0 |
| Other Financing Activity | -2,100 | -382 | -1,394 | -4,069 | 15,246 |
| Financing Cash Flow | $29,110 | $11,654 | $15,087 | $27,810 | $15,246 |
| Beginning Cash Position | 18,533 | 19,126 | 19,993 | 5,742 | N/A |
| End Cash Position | 31,634 | 18,533 | 19,126 | 19,993 | 5,742 |
| Net Cash Flow | $13,101 | $-593 | $-867 | $14,251 | $5,742 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,009 | -12,247 | -15,954 | -13,559 | -9,504 |
| Free Cash Flow | -16,009 | -12,247 | -15,954 | -13,559 | -9,504 |